4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-006835
Chief Executive Officer sold 49,299 shares at an average $65.19 ($3,213,653)
- Chief Executive Officer acquired 49,299 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-05-26 | Exercise or conversion : show line 1 in the form 10b5-1 | +24,282 | $8.82 | $214,167 | 871,154 | D |
| 2026-05-26 | Sale : show line 2 in the form 10b5-1 | −24,282 | $65.08 | $1,580,246 | 846,872 | D |
| 2026-05-27 | Exercise or conversion : show line 3 in the form 10b5-1 | +25,017 | $8.82 | $220,650 | 871,889 | D |
| 2026-05-27 | Sale : show line 4 in the form 10b5-1 | −23,752 | $65.24 | $1,549,561 | 848,137 | D |
| 2026-05-27 | Sale : show line 5 in the form 10b5-1 | −1,265 | $66.28 | $83,846 | 846,872 | D |
| Open-market sales · 49,299 sh · avg $65.19 · $3,213,653 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-05-26 | Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) | +24,282 | 116,926 | D |
| 2026-05-27 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | +25,017 | 91,909 | D |
Loading xslF345X06/marketforms-73281.xml…